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1. Introduction 
Picornavirus-specific proteins are formed by post- 
translational cleavage of high-molecular-weight 
precursor polypeptides [ 11, which appears to be 
accomplished by a set of unidentified proteases of 
both cellular and viral origin [2]. The viral origin of at 
least one of these enzymes is best demonstrated by 
its synthesis in cell-free systems under the direction 
of the viral RNA [3-51. The kinetics of the appearance 
of the protease activity in such systems strongly 
suggests that the enzyme under question is encoded 
in the central part of the encephalomyocarditis (EMC) 
virus genome [4-61. On the other hand, it has been 
reported that it is an EMC virus capsid protein, 
polypeptide y, encoded in the S’end-adjacent part of 
the genome, that is responsible for the virus-specific 
proteolytic activity [7]. The significance of the latter 
finding has, however, been doubtful since there exists 
another virus-specific polypeptide, p22 or ~23, which 
is apparently coded for by the central region of the 
viral RNA molecule and which migrates, upon 
electrophoresis,just slightly ahead of y and, therefore, 
could easily be taken for this capsid protein in poorly 
resolving gels [4,8-lo]. 
Here we present evidence that the polypeptide p22 
is in fact involved in the cleavage of the EMC virus 
precursor polypeptides. 
2. Methods 
2.1. Fractionation of extracts from virus-infected 
cells 
Krebs-2 cells infected with EMC virus at a multi- 
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plicity of 1 O-l 00 p.f.u./cell were incubated with 14C- 
labeled chlorella hydrolysate (10 &i/ml) between 
3.5 and 4.5 h infection at 37°C. Sse extracts from the 
infected cells [ II] were centrifuged in a Beckman 
SW-50.1 rotor at 50 000 rev./mm for 4 h at 4°C and 
the postribosomal supernatant thus obtained was 
chromatographed consecutively on DEAE-52 cellulose 
(Whatman) and phosphocellulose (Sigma) columns 
essentially as in [7], the only significant modification 
being the use of a step-wise rather than a gradient 
elution procedure (see figure legends). 
2.2. Botease activity assay 
A mixture of [35S]methionine-labeled high- 
molecular-weight precursor polypeptides to be used 
as a substrate in the protease activity assay, was 
synthesized in EMC virus RNA-programmed Krebs-2 
cell-free system [ 111 during a 30 mm incubation at 
3O’C. After addition of cycloheximide to 100 pg/ml 
final cont. and glycerol to 10%, the samples were 
frozen and stored at -40°C or -70°C until used. In 
the experiment presented in tig.1, the substrate was 
partially freed from ribosome-associated uncompleted 
polypeptides by centrifugation (105 000 X g, 60 min). 
For the assay, 10 1.11 substrate preparation was usually 
mixed with an equal volume of a fraction to be tested 
for protease activity and the mixture was incubated 
at 30°C for a time indicated in the figure legends. 
2.3. Slab-gel electrophoresis 
Samples to be analyzed were precipitated with 
cold 5% trichloroacetic acid (TCA), washed off with 
5% TCA and then with acetone, dissolved in a disso- 
ciation buffer [ 121 and subjected to electrophoresis 
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in SDS-containing 10% or 12SY0 polyacrylamide slab 
gels. In the experiment presented in fig.1, the reac- 
tion was stopped directly by the addition of the disso 
ciation buffer and electrophoresis was carried out in 
a gradient (8-2OY0) polyacrylamide slab gel. 
3. Results 
To characterize the pattern of cleavage that should 
be expected from the action of the protease sought, 
the high-molecular-weight precursor polypeptide 
substrate synthesized in vitro upon a short incubation 
with EMC virus RNA was incubated with an extract 
from the virus-infected cells. Figure 1 shows that the 
shortest (5 min) incubation of the substrate-enzyme 
mixture resulted in the appearance of the following 
polypeptides: Dl, a, G, and two smaller polypeptides 
withanapp.Mrof 14000and 12000,p14andp12, 
respectively. Upon a somewhat longer exposure of 
the substrate to the extract from infected cells, capsid 
polypeptides E and y were formed. The quantity of 
capsid polypeptides appeared to slowly increase, 
while the quantities of p 14 and p 12 decrease during 
the incubation. In general, the pattern of cleavage 
indicates that: 
6) 
(ii) 
The substrate contained precursor polypeptides, 
preA and A, corresponding to the 5’-end-adjacent 
part of the EMC virus genome; 
The protease present in the extracts from 
virus-infected cells were able to cleave these 
precursors to capsid polypeptides (e, (Y and y), 
non-capsid polypeptide G and small polypeptides 
p14 and p12. 
The first steps of purification of the virus-specific 
protease were by ionexchange chromatography 
essentially as in [7]. The results of DEAE-cellulose 
chromatography of r4C-labeled virus-specific poly- 
peptides present in the extract from infected cells are 
shown on the left panel of fig.2. Aliquots of each 
fraction were assayed for protease activity and the 
results obtained are shown on the right panel of fig.2. It 
should be noted that both the substrate and the 
enzyme preparations were radioactively labeled in our 
experiments. However, a significant difference in the 
specific radioactivities of 14C- and 35S-labeled amino 
acids incorporated in proteins of the enzyme and the 
substrate preparations, respectively, allowed us to 
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Fig.l. Kinetics of the cleavage of precursor polypeptrdes by 
extracts from EMC virus-infected Krebs-2 cells. A preparation 
of [ 35S]methionine-labeled substrate polypeptides was mixed 
with 0.5 vol. Saa from infected cells and incubated at 30°C. 
At time intervals indicated aliquots were withdrawn and 
analyzed in an SDS-containing radient Q-20%) polyacryla- 
mide slab gel. 
follow the substrate 3sS-label redistribution without 
any appreciable interference from the 14C-label 
present in the virus-specific polypeptides of the 
enzyme preparations. In fact, the quantity of 
14C-labeled material present in the protease activity 
assays was l-2 orders of magnitude (fig.2) or Z=2 
orders of magnitude (fig.3) lower than that used 
for the detection of virus-specific polypeptides in 
chromatographic fractions. 
Judging by the appearance of stable cleavage 
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Fig.2. Fractionation on DEAE-cellulose of the postribosomal 
supernatant from infected cells and assay of the fractions 
obtained for protease activity. 10 ml of a postribosomal 
supernatant (see Methods) were diluted lo-fold with buffer A 
(0.01 M Tris-HCl (pH 7.5), 0.01 M 2-mercaptoethanol, 10% 
glycerol) containing 0.01 M KCl and applied onto a DEAE 
cellulose column (6 ml) equilibrated with the same solution. 
The column was washed off with 35 ml 0.0’1 M KCl in buffer 
A and then eluted consecutively with 15-25 ml portions of 
buffer A containing increasing concentrations of KCl as indi- 
cated over the electrophoregram. Radioactivity in the acid- 
insoluble material in aliquots of the flow-through (f) and 3 ml 
fractions was determined and fractions of each eluate with 
maximal radioactivity were pooled. A volume indicated 
below the electrophoregram was withdrawn from each pool 
and the proteins were subjected to electrophoresis (left panel 
of fig.). Slot V contained 14C-labeled extract from the virus- 
infected cells. Aliquots of the same chromatographic eluates, 
10 ~1 each, except the flowthrough (f) where a 20 ~1 portion 
was used, were mixed with 10 ~1 aliquots of the %-labeled 
substrate polypeptides and were incubated at 30°C for 4 h. 
The results of an electrophoretic analysis of products formed 
upon this incubation are presented on the right panel,of the 
figure. Slot C contained the control substrate incubated 
without any additions. Electrophoresis was performed in 
an SDS-containing 10% polyacrylamide slab gel. 
products, polypeptides IJ and G, the highest proteo- 
lytic activity seemed to be present in a fraction eluted 
from DEAE-cellulose with 0.1 M KCl. However, it 
should be kept in mind that the flowthrough material, 
which was considerably diluted, also displayed a 
marked activity. This material was relatively enriched 
in ~22. Therefore, the 0.1 M KC1 eluate and the flow- 
through material were subjected to further purifica- 
tion by phosphocellulose chromatography. 
As shown in fig.3, there was a clear-cut correlation 
between the protease activity and the presence of ~22. 
In both cases (fig.3A,3B),p22 was especially abundant 
in the 0.25 M K-phosphate eluate and it was this 
fraction that displayed a maximal proteolytic activity. 
It is noteworthy that the material not retained by 
phosphocellulose and containing significant amounts 
of y was essentially incapable of performing the 
cleavage; neither was there a correlation between the 
enzyme activity and the presence of polypeptide G 
(see fig3B). It may be noted that the active fractions 
obtained by chromatography appeared to fail to bring 
about the formation of significant amounts of poly- 
peptides E and y, although small quantities of these 
polypeptides could well be overlooked. 
4. Discussion 
The results of this study strongly suggest hat 
virus-specific polypeptide p22 is involved in the for- 
mation of capsid proteins as well as polypeptide G 
from their precursor(s). The unpublished preliminary 
observations of another group also suggest hat p22 is 
a virus-coded protease [ 51. 
It should be admitted that preparations of p22 
used were somewhat contaminated with trace amounts 
of some other virus-specific polypeptides and unknown 
amounts of host cell proteins. However, the protease 
activity in chromatographic fractions correlated with 
the presence of none of virus-specific polypeptides, 
except ~22. Consecutive chromatography of EMC 
virus-specific polypeptides on DEAE-cellulose, 
SepharosedB and phosphocellulose in the presence of 
8 M urea resulted in preparations of p22 lacking 
detectable amounts of other virus-specific polypeptides; 
these preparations displayed a protease activity after 
removal of urea (data not shown). As far as cellular 
contaminants are concerned, it should be noted that 
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Fig.3. Fractionation on phosphocelhtfose of the ~ow~rou~h material (a) and the 0.1 M KC1 eluate (b) obtained after DEAE- 
celluiose chromato~aphy. Before c~omatography, the 0.1 M KC1 eluate was dihrted with buffer A (see legend to f&2), so that 
Kc1 was final cont. 0.03 M. The chromatography was performed on a phosphocellulose column (1 ml) equilibrated with buffer B 
(0.05 M K-phosphate (pH 6.8), 0.0005 M 2-mercaptoethanol, 10% glycerol). The unadsorbed material was washed off with 
0.03 M KC1 in buffer A and the elution was performed with 7-10 ml portions of buffer B with increasing concentrations of 
K-phosphate as indicated over the electrophoregram. For the protease activity assay, 10 ~1 aliquots of each fraction were used, 
except for the ~owthrough material (r) in panel (a) where a 20 ~1 aliquot was used. Electrophoresis was performed in an SDS- 
containing 12.5% polyacrylamide slab gel. For other explanations ee legend to fig.2. 
extracts from uninfected cells fail to accomplish the 
cleavage of preA (A) [3,4]. This important fact, how- 
ever, cannot be regarded as a rigorous disproof of the 
involvement of some cellular protein(s) in the forma- 
tion of EMC virus capsid polypeptides and polypep- 
tide G from their precursors. The cleavage system 
might be composed of more than one enzyme and 
activator protein(s) of viral and host origin. In this 
respect, the apparent absence of polypeptides E and 
y from the p22-mediated cleavage products may be 
of some interest. Certainly, this absence may simply 
be due to the low concentration of p22 present in the 
assay system and a relatively low susceptibility of the 
corresponding cleavage sites to the proteolytic action 
of ~22; indeed e and y are the last to appear upon the 
4 
precursor cleavage by extracts from infected cells 
(fig.1). Alternatively, the failure of p22 to form E and 
y may be due to a demand for an additional protein(s) 
involved in the cleavage. The solution of this problem 
requires the availability of more purified and con- 
centrated preparations of ~22. 
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